Cancer Research Institute (CRI)

29 cancers are now treatable with immunotherapy, thanks to the work of the Cancer Research Institute. Discover how CRI is empowering patients and spreading hope on a global scale, in our new Impact Report: https://bit.ly/4hiBiGT #CancerResearch #BreastCancer #Immunotherapy #ClinicalTrial #PatientAdvocate

Join the GivingTuesday movement on December 3, and give for a world immune to cancer! Drive discoveries in cancer immunotherapy research by making a donation to the Cancer Research Institute on GivingTuesday, or by making an early gift today. Donations up to $100,000 will be matched by a generous board member only until December 31, 2024. Double your impact: https://bit.ly/3AGCXWh #GivingTuesday #CancerResearch #Immunotherapy

“Immunotherapy actually saved my life when I had no other options,” shares CRI ImmunoAdvocate and breast cancer survivor, Karen. Discover how the Cancer Research Institute is bringing the promise of immunotherapy to more patients, and transforming lives on a global scale: https://bit.ly/4hiBiGT #CancerResearch #BreastCancer #PatientAdvocate

How is immunotherapy making an impact against lung cancer, and how can lung cancer screenings change a person's prognosis? Explore the answers to these questions, and gain additional insights, during November's Lung Cancer Awareness Month, from Yale Medicine: https://bit.ly/3UEyKcJ #LungCancerAwarenessMonth #LungCancerResearch #CancerResearch #Immunotherapy

"Despite advances in cancer screening, detection, diagnosis, and management, many patients face challenges in accessing patient-centered, high-quality care in the United States due to systemic, cultural, and individual barriers," the President's Cancer Panel outlines. Dive into their latest report to discover recommendations from Panel members, including CRI Scientific Advisory Council Associate Director Dr. Elizabeth Jaffee of Johns Hopkins Medicine, specifically regarding how patient navigation can be enhanced with technology to improve equity in cancer care: https://bit.ly/3Ok9EMm #CancerResearch #HealthEquity #CancerPatient

A new publication in Springer Nature's Nature from Harvard Medical School and Trinity College Dublin researchers, including former CRI CLIP Investigator Dr. Lydia Lynch, showcases that an immune molecule in adipose tissue, interleukin-17A (IL-17A), plays a regulatory role in fat storage, "a process significantly influenced by a stable and well-regulated circadian rhythm. Mice missing molecular clock genes in these cells exhibited impaired fat processing and storage, while whole-body metabolic analyses further revealed disrupted metabolic rhythms and irregular core body temperature regulation," Trinity College Dublin describes. Learn more: https://lnkd.in/gBFnHrWD #ImmuneSystem #CircadianRhythm

“The field is what it is today because CRI continues to be laser-focused on breakthrough immunotherapy research,” emphasizes CRI Scientific Advisory Council Director and 2018 Nobel Laureate Dr. James P. Allison. The Cancer Research Institute is committed to building a community of scientific talent by supporting outstanding researchers across diverse disciplines. Our investment in fellowships, awards, and integration programs empowers CRI-funded scientists to take risks, innovate, and bridge the gap between research and clinical practice. Explore: https://bit.ly/4hiBiGT #CancerResearch #Immunotherapy

How can artificial intelligence help in designing better immunotherapies, and how can innovations in AI and machine learning benefit patients and caregivers? Explore the new opportunities artificial intelligence and machine learning are unlocking for the future of immunotherapy, with Dr. Elana Fertig of The Johns Hopkins University. Dive into the newest video in the Cancer Research Institute's Cancer Immunotherapy and You™ Patient Education webinar series, today: https://bit.ly/4eHABEu #ArtificialIntelligence #MachineLearning #CancerResearch #Immunotherapy #CRIWebinar

Did you know? Pancreatic cancer is the third leading cause of cancer related deaths in the United States. During November's Pancreatic Cancer Awareness Month, explore new advances and innovations against this complex and deadly disease, and discover how CRI-funded researchers, including CRI Postdoctoral Fellow Dr. Chiara Falcomatà at Icahn School of Medicine at Mount Sinai, are making an impact: https://bit.ly/3ZdkLwU #PancreaticCancer #CancerResearch #Immunotherapy #pancsm

CRI Lloyd J. Old STAR Dr. Gavin Dunn of Massachusetts General Hospital's pioneering efforts are laying the foundation for future clinical trials and combination therapies, offering renewed hope for patients facing brain cancer. Discover how CRI-funded researchers, including Dr. Dunn, are making a difference in the fight against cancer, by exploring our latest Impact Report: https://bit.ly/4hiBiGT #CancerResearch #GBM #Immunotherapy